NUCLEUS Trademark

Trademark Overview


On Wednesday, February 17, 2021, a trademark application was filed for NUCLEUS with the United States Patent and Trademark Office. The USPTO has given the NUCLEUS trademark a serial number of 79308449. The federal status of this trademark filing is REGISTERED as of Tuesday, June 7, 2022. This trademark is owned by Cochlear Limited. The NUCLEUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; medical preparations for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; pharmaceutical drugs for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; corticosteroids; dexamethasone; anti-inflammatory, anti-fibrotic, anti-apoptotic, anti-oxidant, immunosuppressing, neuroprotective, neurotrophic and neuroregenerative drugs; pharmaceutical sprays for the body for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; medical disinfectants; antiseptics; disinfectant medicated cleaning preparations for instruments; chemical reagen...
nucleus

General Information


Serial Number79308449
Word MarkNUCLEUS
Filing DateWednesday, February 17, 2021
Status700 - REGISTERED
Status DateTuesday, June 7, 2022
Registration Number6749230
Registration DateTuesday, June 7, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; medical preparations for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; pharmaceutical drugs for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; corticosteroids; dexamethasone; anti-inflammatory, anti-fibrotic, anti-apoptotic, anti-oxidant, immunosuppressing, neuroprotective, neurotrophic and neuroregenerative drugs; pharmaceutical sprays for the body for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; medical disinfectants; antiseptics; disinfectant medicated cleaning preparations for instruments; chemical reagents for medical purposes; chemical preparations for medical purposes, namely, for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCochlear Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU

Party NameCochlear Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU

Party NameCochlear Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Tuesday, September 20, 2022FINAL DISPOSITION NOTICE SENT TO IB
Monday, September 19, 2022FINAL DISPOSITION PROCESSED
Wednesday, September 7, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, August 14, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, June 7, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 7, 2022REGISTERED-PRINCIPAL REGISTER
Friday, April 29, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, April 1, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Monday, February 14, 2022NOTIFICATION PROCESSED BY IB
Wednesday, January 26, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 26, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 14, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 13, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 5, 2021REFUSAL PROCESSED BY IB
Friday, June 11, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 11, 2021REFUSAL PROCESSED BY MPU
Tuesday, June 8, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 7, 2021NON-FINAL ACTION WRITTEN
Thursday, June 3, 2021ASSIGNED TO EXAMINER
Tuesday, April 13, 2021APPLICATION FILING RECEIPT MAILED
Friday, April 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 8, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB